Archivio delibere
Seduta del 15/06/2016
Delibera del 15 Giugno, n. 183 [file.pdf]
Autorizzazione dello studio dal titolo: “A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment” – STUDIO SOLAR-1 – protocollo di studio CBYL719C2301.
Autorizzazione dello studio dal titolo: “A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment” – STUDIO SOLAR-1 – protocollo di studio CBYL719C2301.
Data seduta:15/06/2016
In pubblicazione dal: 15/06/2016-al: 30/06/2016
In pubblicazione dal: 15/06/2016-al: 30/06/2016